Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2011 Jun;22(6):1113-21.
doi: 10.1681/ASN.2010111155. Epub 2011 Apr 21.

Hemodialysis vascular access modifies the association between dialysis modality and survival

Jeffrey Perl  1 , Ron Wald, Philip McFarlane, Joanne M Bargman, Edward Vonesh, Yingbo Na, S Vanita Jassal, Louise Moist
Affiliations
Comparative Study

Hemodialysis vascular access modifies the association between dialysis modality and survival

Jeffrey Perl et al. J Am Soc Nephrol. 2011 Jun.

Abstract

Several comparisons of peritoneal dialysis (PD) and hemodialysis (HD) in incident patients with ESRD demonstrate superior survival in PD-treated patients within the first 1 to 2 years. These survival differences may be due to higher HD-related mortality as a result of high rates of incident central venous catheter (CVC) use or due to an initial survival advantage conferred by PD. We compared the survival of incident PD patients with those who initiated HD with a CVC (HD-CVC) or with a functional arteriovenous fistula or arteriovenous graft (HD-AVF/AVG). We used multivariable piece-wise exponential nonproportional and proportional hazards models to evaluate early (1 year) mortality as well as overall mortality during the period of observation using an intention-to-treat approach. We identified 40,526 incident adult dialysis patients from the Canadian Organ Replacement Register (2001 to 2008). Compared with the 7412 PD patients, 1-year mortality was similar for the 6663 HD-AVF/AVG patients but was 80% higher for the 24,437 HD-CVC patients (adjusted HR, 1.8; 95% confidence intervals [CI], 1.6 to 1.9). During the entire period of follow-up, HD-AVF/AVG patients had a lower risk for death, and HD-CVC patients had a higher risk for death compared with patients on PD. In conclusion, the use of CVCs in incident HD patients largely accounts for the early survival benefit seen with PD.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Survival curves for HD-CVC (short-dashed line), HD-AVF/AVG (long-dashed line), and PD (solid line) demonstrate higher 1-year mortality in HD-CVC patients. (A) Unadjusted. (B) Adjusted on the basis of a stratified Cox proportional Hazards model stratified by HD-CVC, PD, and HD-AVF/AVG and adjusted for age, race, gender, era of dialysis initiation, end-stage renal disease comorbidity index, primary renal diagnosis, serum albumin, eGFR, province of treatment, and late referral.
Figure 2.
Figure 2.
Hemodialysis vascular access affects the association between modality and survival in selected subgroups. *P value for interaction (int). The models were adjusted for age, race, gender, era of dialysis initiation, ESRD comorbidity index, primary renal diagnosis, serum albumin, estimated GFR, province of treatment and late referral.
See this image and copyright information in PMC

Comment in

References

    1. Oliver MJ, Rothwell DM, Fung K, Hux JE, Lok CE: Late creation of vascular access for hemodialysis and increased risk of sepsis. J Am Soc Nephrol 15: 1936–1942, 2004 - PubMed
    1. Moist LM, Trpeski L, Na Y, Lok CE: Increased hemodialysis catheter use in Canada and associated mortality risk: Data from the Canadian Organ Replacement Registry 2001–2004. Clin J Am Soc Nephrol 3: 1726–1732, 2008 - PMC - PubMed
    1. Polkinghorne KR: Vascular access practice in hemodialysis: Instrumental in determining patient mortality. Am J Kidney Dis 53: 359–362, 2009 - PubMed
    1. Lacson E, Jr., Wang W, Hakim RM, Teng M, Lazarus JM: Associates of mortality and hospitalization in hemodialysis: Potentially actionable laboratory variables and vascular access. Am J Kidney Dis 53: 79–90, 2009 - PubMed
    1. Pisoni RL, Arrington CJ, Albert JM, Ethier J, Kimata N, Krishnan M, Rayner HC, Saito A, Sands JJ, Saran R, Gillespie B, Wolfe RA, Port FK: Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: An instrumental variable analysis. Am J Kidney Dis 53: 475–491, 2009 - PubMed

Publication types

MeSH terms